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Cognitive dysfunction is considered a core deficit of  schizophrenia, which 
currently lacks effective pharmacological treatment. In order to identify novel 
and more effective drug treatments, translational experimental animal models 
of  cognitive dysfunction are required. Schizophrenia-like symptoms can be 
induced in humans by phencyclidine (PCP). PCP also induces schizophrenia-
like behavioural changes in experimental animals and several of  these effects 
can be ameliorated by pretreatment with nitric oxide (NO) synthase inhibitors. 
This suggests an important role of  NO in the effects of  PCP.  The general 
aim of  the present thesis was to further investigate the effects of  PCP, and 
the role of  NO in these effects, in translational experimental animal models of 
cognitive dysfunction. Three behavioural models in rodents with relevance to 
schizophrenia were used. Pre-attentive information processing and non-
associative learning were studied using the prepulse inhibition and habituation 
of  the acoustic startle response models respectively. Additionally, selective 
attention was investigated using latent inhibition in taste aversion 
conditioning.  Systemic administration of  PCP to mice caused a deficit in 
habituation of  the acoustic startle response. This effect of  PCP was 
attenuated by pretreatment with the NO synthase inhibitor NG-nitro-L-
arginine methyl ester (L-NAME). Furthermore, systemic administration of  
PCP potentiated latent inhibition in taste aversion conditioning. This effect 
could be normalized by pretreatment with L-NAME. Finally, acute and sub-
chronic inhibition of  NO synthase substrate (L-arginine) availability, using the 
amino acid L-lysine, attenuated the deficit in prepulse inhibition induced by 
PCP. In the present thesis PCP was shown to induce deficits in three 
translational animal models of  cognitive dysfunction associated with 
schizophrenia. Additionally, blocking NO production ameliorated the deficits 
induced by PCP. These findings lend further support to the notion that drugs 
targeting central NO production could be of  therapeutic value in the 
treatment of  cognitive dysfunction in schizophrenia. In addition, they indicate 
that L-arginine availability may be an important regulatory mechanism of  NO 
production in the brain.
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